JAC Advance Access published online on November 1, 2002
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkf242
© 2002 by The British Society for Antimicrobial Chemotherapy
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Paper
1 Microbiology, Otago
School of Medical Sciences, University of Otago, Dunedin, New Zealand
* Corresponding author. E-mail: sandy.smith{at}stonebow.otago.ac.nz.
Received 30 May 2002
; revised 10 September 2002
; accepted 11 September 2002
In New Zealand, it is estimated that greater than half
of the methicillin-resistant Staphylococcus aureus (MRSA)
strains recovered from patients belong to what has been termed Western Samoan
phage pattern types 1 and 2 (WSPP1, WSPP2). These strains differ
from classical MRSA isolates in terms of their lack of multiresistance
and community occurrence, suggesting that such strains possess properties
and/or characteristics different from those of other MRSA. To address
this hypothesis, 10 WSPP1 and WSPP2 isolates from Western Samoa,
New Zealand and Australia were compared with common hospital MRSA
isolates. All WSPP isolates were identical with regard to pulsed-field
gel electrophoretic pattern of SmaI-digested DNA,
coagulase gene restriction fragment length polymorphism pattern
and localization of mecA to a 194 kb SmaI digestion
fragment. The WSPP strains were no more resistant/sensitive to various
environmental stresses (e.g. skin fatty acids, UV light, desiccation)
compared with hospital epidemic MRSA strains, except for their higher
tolerance to salt. In terms of virulence, the WSPP MRSA were quantitatively
better at attaching to the epithelial cell line HEp2, were uniformly
egg-yolk opacity factor negative and produced higher levels of haemolytic
toxins compared with non-WSPP MRSA isolates.
Keywords: community MRSA, phenotypic and molecular characteristics
Phenotypic and molecular characterization of community
occurring, Western Samoan phage pattern methicillin-resistant Staphylococcus aureus
2 Biochemistry, Otago
School of Medical Sciences, University of Otago, Dunedin, New Zealand
3 Middlemore Hospital and Diagnostic
Medlab, Auckland, New Zealand
4 Institute
of Environmental Science and Research,
Porirua, New Zealand
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
H. Karauzum, T. Ferry, S. de Bentzmann, G. Lina, M. Bes, F. Vandenesch, M. Schmaler, B. Berger-Bachi, J. Etienne, and R. Landmann Comparison of Adhesion and Virulence of Two Predominant Hospital-Acquired Methicillin-Resistant Staphylococcus aureus Clones and Clonal Methicillin-Susceptible S. aureus Isolates Infect. Immun., November 1, 2008; 76(11): 5133 - 5138. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Lee, M. Ender, R. Adhikari, J. M. B. Smith, B. Berger-Bachi, and G. M. Cook Fitness Cost of Staphylococcal Cassette Chromosome mec in Methicillin-Resistant Staphylococcus aureus by Way of Continuous Culture Antimicrob. Agents Chemother., April 1, 2007; 51(4): 1497 - 1499. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ramdani-Bouguessa, M. Bes, H. Meugnier, F. Forey, M.-E. Reverdy, G. Lina, F. Vandenesch, M. Tazir, and J. Etienne Detection of Methicillin-Resistant Staphylococcus aureus Strains Resistant to Multiple Antibiotics and Carrying the Panton-Valentine Leukocidin Genes in an Algiers Hospital Antimicrob. Agents Chemother., March 1, 2006; 50(3): 1083 - 1085. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Qi, M. Ender, F. O'Brien, A. Imhof, C. Ruef, N. McCallum, and B. Berger-Bachi Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus in Zurich, Switzerland (2003): Prevalence of Type IV SCCmec and a New SCCmec Element Associated with Isolates from Intravenous Drug Users J. Clin. Microbiol., October 1, 2005; 43(10): 5164 - 5170. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Adhikari, G. C. Scales, K. Kobayashi, J. M. B. Smith, B. Berger-Bachi, and G. M. Cook Vancomycin-induced deletion of the methicillin resistance gene mecA in Staphylococcus aureus J. Antimicrob. Chemother., August 1, 2004; 54(2): 360 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. O'Brien, T. T. Lim, F. N. Chong, G. W. Coombs, M. C. Enright, D. A. Robinson, A. Monk, B. Said-Salim, B. N. Kreiswirth, and W. B. Grubb Diversity among Community Isolates of Methicillin-Resistant Staphylococcus aureus in Australia J. Clin. Microbiol., July 1, 2004; 42(7): 3185 - 3190. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tacconelli, L. Venkataraman, P. C. De Girolami, and E. M. C. D'Agata Methicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: distinguishing between community-acquired versus healthcare-associated strains J. Antimicrob. Chemother., March 1, 2004; 53(3): 474 - 479. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Liassine, R. Auckenthaler, M.-C. Descombes, M. Bes, F. Vandenesch, and J. Etienne Community-Acquired Methicillin-Resistant Staphylococcus aureus Isolated in Switzerland Contains the Panton-Valentine Leukocidin or Exfoliative Toxin Genes J. Clin. Microbiol., February 1, 2004; 42(2): 825 - 828. [Abstract] [Full Text] [PDF] |
||||



